Acceptance for Human Papilloma virus vaccines, experience at tertiary care centre of northern india: a hospital-based survey
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20191941Keywords:
Carcinoma cervix, Cervarix, Gardasil, HPV vaccineAbstract
Background: Acceptance of HPV vaccine is varying widely worldwide in range of 10-70%. For increasing the acceptability for HPV vaccine, finding the obstacles and catering them diligently is required. The aim of the study was to find out acceptability rate for HPV vaccine in northern India and various obstacles and facilitators affecting acceptance of HPV vaccine.
Methods: A questionnaire based descriptive study was done in the Department of Obstetrics and Gynecology of King George Medical University, Lucknow, Uttar Pradesh, India from June 2016 to June 2017. Questionnaire was filled by doctor after taking face to face interview of individuals. Ethical approval was obtained from the Institutional Ethical Committee of the KGMU, Lucknow, Uttar Pradesh, India. (1689/Ethics/R cell/17) acceptability rate and various facilitators and obstacles for HPV vaccine were studied. For continuous variables mean with standard deviation was used. For categorical variables frequencies and percentages were used. IBM SPSS statistics applied.
Results: A total of 302 cases were face to face interviewed, amongst which, 70 cases (23%) showed acceptability and 232 did not accept the vaccine. The most common obstacles were lack of knowledge and high monetary cost being the cause of nonacceptance in 48.3% and 33.6% of cases respectively.
Conclusions: Higher level of awareness and knowledge about HPV vaccine and inclusion in government immunization programmed may increase acceptability.
References
Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992;79(3):328-7.
Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265(4):472-7.
Chatterjee A. The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon. Expert Review Vaccines. 2014;13(11):1279-90.
Nigam A, Saxena P, Acharya AS, Mishra A, Batra S. HPV vaccination in India: critical appraisal. ISRN Obstet Gynecol. 2014;2014.
Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40(2):108-15.
Dahlström LA, Tran TN, Lundholm C, Young C, Sundström K, Sparén P. Attitudes to HPV vaccination among parents of children aged 12‐15 years-A population‐based survey in Sweden. Int J Cancer. 2010;126(2):500-7.
Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Lo SS, et al. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications. BJOG: An Int J Obstetr Gynaecol. 2009 1;116(4):501-10.
Montgomery MP, Dune T, Shetty PK, Shetty AK. Knowledge and acceptability of human papillomavirus vaccination and cervical cancer screening among women in Karnataka, India. J Canc Edu. 2015;30(1):130-7.
Weiss TW, Rosenthal SL, Zimet GD. Attitudes toward HPV vaccination among women aged 27 to 45. ISRN Obstet Gynecol. 2011;2011.
Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstetr Gynecol. 2008;111(5):1103-10.
Lefkowitz ES, Kelly KM, Vasilenko SA, Maggs JL. Correlates of human papillomavirus vaccination among female university students. Women Health. 2014;54(6):487-501.
Hussain AN, Alkhenizan A, McWalter P, Qazi N, Alshmassi A, Farooqi S, et al. Attitudes and perceptions towards HPV vaccination among young women in Saudi Arabia. J Family Comm Med. 2016;23(3):145.
Östensson E, Fröberg M, Leval A, Hellström AC, Bäcklund M, Zethraeus N, et al. Cost of preventing, managing, and treating human papillomavirus (HPV)-related diseases in Sweden before the introduction of quadrivalent HPV vaccination. PloS One. 2015;10(9):e0139062.
Feiring B, Laake I, Molden T, Cappelen I, Håberg SE, Magnus P, et al. Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway. BMJ open. 2015;5(5):e006422.
Ogilvie GS, Cook DA, Taylor DL, Rank C, Kan L, Yu A, et al. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada. Vaccine. 2013;31(7):1129-33.
Belani HK, Sekar P, Guhaniyogi R, Abraham A, Bohjanen PR, Bohjanen K. Human papillomavirus vaccine acceptance among young men in Bangalore, India. Int J Dermat. 2014;53(11):e486-91.
Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006;24(16):3087-94.
Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007;25(11):1945-52.
Mehta S, Rajaram S, Goel G, Goel N. Awareness about human papilloma virus and its vaccine among medical students. Indian journal of community medicine: official publication of Indian Assoc Preven Social Med. 2013;38(2):92.
Chawla PC, Chawla A, Chaudhary S. Knowledge, attitude and practice on human papillomavirus vaccination: A cross-sectional study among healthcare providers. Indian J Med Res. 2016;144(5):741.
Molokwu J, Penaranda E, Flores S, Shokar NK. Evaluation of the effect of a promotora-led educational intervention on cervical cancer and human papillomavirus knowledge among predominantly Hispanic Primary Care patients on the US-Mexico border. J Canc Edu. 2016;31(4):742-8.
Barnard JG, Dempsey AF, Brewer SE, Pyrzanowski J, Mazzoni SE, O'leary ST. Facilitators and barriers to the use of standing orders for vaccination in obstetrics and gynecology settings. Am J Obstet Gynecol. 2017;216(1):69-e1.
Donadiki EM, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, Lopez de Andres A, Jimenez-Trujillo I, et al. Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece. Human Vaccines Immunotherap. 2013;9(2):300-5.
Donadiki EM, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, de Andrés AL, Velonakis EG. Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake. Vaccine. 2012;30(49):6967-0.
Vogtmann E, Harlow SD, Valdez AC, Valdez JC, Ponce EL. HPV knowledge in Mexican college students: implications for intervention programmes. Health Social Care Community. 2011;19(2):148-57.
Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. British J Canc. 2008;99(2):225.
Al Moustafa AE, Al-Awadhi R, Missaoui N, Adam I, Durusoy R, Ghabreau L, et al. Human papillomaviruses-related cancers: Presence and prevention strategies in the Middle East and North African Regions. Human Vaccines Immunotherap. 2014;10(7):1812-1.
Basu P, Mittal S. Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern India. J Obstet Gynaecol Res. 2011;37(5):393-401.
Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health. 2013;103(1):164-9.
Hswen Y, Gilkey MB, Rimer BK, Brewer NT. Improving physician recommendations for HPV vaccination: the role of professional organizations. Sexually Transmitted Dis. 2017;44(1):42.
